Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for

See also
Status	Clinical Trial	Phase
Completed	`NCT01701687` - Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease	N/A
Recruiting	`NCT05121870` - Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis	Phase 2
Recruiting	`NCT05421351` - Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
Not yet recruiting	`NCT05086536` - Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis
Recruiting	`NCT03820271` - New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation	N/A
Recruiting	`NCT06134544` - Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis	N/A
Recruiting	`NCT06223893` - CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis	N/A
Completed	`NCT02219477` - A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis	Phase 3
Recruiting	`NCT05734001` - Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.	N/A
Terminated	`NCT04775329` - Primary Prophylaxis for Spontaneous Bacterial Peritonitis	Phase 2/Phase 3
Recruiting	`NCT04422223` - Prospective Cohort Study of Disease and Outcomes in Cirrhosis
Completed	`NCT01326949` - Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis	N/A
Recruiting	`NCT06396897` - Hospital @ Home Model of Care for Cirrhosis
Not yet recruiting	`NCT06306781` - A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis	N/A
Recruiting	`NCT05227846` - Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)	Phase 1
Not yet recruiting	`NCT05937048` - Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).	N/A
Active, not recruiting	`NCT03205345` - Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis	Phase 2
Terminated	`NCT03462576` - Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17
Not yet recruiting	`NCT05224960` - Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)	Phase 2
Terminated	`NCT04112199` - A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites	Phase 2

NCT number	NCT02786017
Study type	Interventional
Source	Chinese Academy of Sciences
Contact	Zhifeng Xiao, Ph.D
Phone	86-10-82614420
Email	zfxiao@genetics.ac.cn
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	May 2016
Completion date	December 2020

Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms